Source: Medical Devices Business Review

Vertera Spine: Vertera Spine secures FDA clearance for Coalesce lumbar interbody fusion device

Vertera Spine has secured an approval from the US Food and Drug Administration (FDA) for its Coalesce lumbar interbody fusion device.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Christopher SD Lee's photo - President & CEO of Vertera Spine

President & CEO

Christopher SD Lee

CEO Approval Rating

73/100

Read more